KTRA logo

Kintara Therapeutics (KTRA) Total Liabilities

Annual Total Liabilities

$2.44 M
-$803.00 K-24.72%

01 June 2024

KTRA Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$2.44 M
+$921.00 K+60.43%

01 June 2024

KTRA Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KTRA Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-24.7%-30.2%
3 y3 years-17.4%-23.1%
5 y5 years+18.1%+82.6%

KTRA Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time-52.4%-82.8%

Kintara Therapeutics Total Liabilities History

DateAnnualQuarterly
June 2024
$2.44 M(-24.7%)
$2.44 M(+60.4%)
Mar 2024
-
$1.52 M(-25.6%)
Dec 2023
-
$2.05 M(-41.5%)
Sept 2023
-
$3.50 M(+7.9%)
June 2023
$3.25 M(-21.8%)
$3.25 M(+10.0%)
Mar 2023
-
$2.95 M(-11.0%)
Dec 2022
-
$3.32 M(-7.6%)
Sept 2022
-
$3.59 M(-13.5%)
June 2022
$4.15 M(+40.2%)
$4.15 M(+21.7%)
Mar 2022
-
$3.41 M(-5.6%)
Dec 2021
-
$3.62 M(+13.7%)
Sept 2021
-
$3.18 M(+7.4%)
June 2021
$2.96 M(+10.7%)
$2.96 M(+8.3%)
Mar 2021
-
$2.73 M(-5.8%)
Dec 2020
-
$2.90 M(+12.7%)
Sept 2020
-
$2.58 M(-3.7%)
June 2020
$2.67 M(+29.2%)
$2.67 M(+93.6%)
Mar 2020
-
$1.38 M(+34.5%)
Dec 2019
-
$1.03 M(-23.3%)
Sept 2019
-
$1.34 M(-35.3%)
June 2019
$2.07 M(+26.2%)
$2.07 M(+72.8%)
Mar 2019
-
$1.20 M(-5.5%)
Dec 2018
-
$1.27 M(+17.5%)
Sept 2018
-
$1.08 M(-34.2%)
June 2018
$1.64 M(+23.0%)
$1.64 M(-18.7%)
Mar 2018
-
$2.02 M(-9.6%)
Dec 2017
-
$2.23 M(+46.0%)
Sept 2017
-
$1.53 M(+14.8%)
DateAnnualQuarterly
June 2017
$1.33 M(-11.0%)
$1.33 M(+20.0%)
Mar 2017
-
$1.11 M(+24.5%)
Dec 2016
-
$892.20 K(-16.8%)
Sept 2016
-
$1.07 M(-28.4%)
June 2016
$1.50 M(-55.9%)
$1.50 M(-18.8%)
Mar 2016
-
$1.84 M(-10.9%)
Dec 2015
-
$2.07 M(-41.7%)
Sept 2015
-
$3.55 M(+4.4%)
June 2015
$3.40 M(-17.6%)
$3.40 M(+54.7%)
Mar 2015
-
$2.20 M(+7.6%)
Dec 2014
-
$2.04 M(-48.7%)
Sept 2014
-
$3.98 M(-41.6%)
June 2014
$4.12 M(-19.7%)
-
Mar 2014
-
$6.81 M(+32.7%)
Dec 2013
$5.14 M(>+9900.0%)
$5.14 M(-9.8%)
Sept 2013
-
$5.70 M(-60.0%)
June 2013
-
$14.23 M(+46.6%)
Mar 2013
-
$9.71 M(>+9900.0%)
Dec 2012
-
$19.60 K(+50.8%)
Sept 2012
-
$13.00 K(+30.0%)
June 2012
-
$10.00 K(0.0%)
June 2012
$10.00 K(>+9900.0%)
-
Mar 2012
-
$10.00 K(+104.1%)
Dec 2011
-
$4900.00(>+9900.0%)
Sept 2011
-
$0.00(0.0%)
June 2011
$0.00(-100.0%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
Dec 2010
-
$0.00(-100.0%)
June 2010
$700.00
$700.00

FAQ

  • What is Kintara Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Kintara Therapeutics?
  • What is Kintara Therapeutics annual total liabilities year-on-year change?
  • What is Kintara Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Kintara Therapeutics?
  • What is Kintara Therapeutics quarterly total liabilities year-on-year change?

What is Kintara Therapeutics annual total liabilities?

The current annual total liabilities of KTRA is $2.44 M

What is the all time high annual total liabilities for Kintara Therapeutics?

Kintara Therapeutics all-time high annual total liabilities is $5.14 M

What is Kintara Therapeutics annual total liabilities year-on-year change?

Over the past year, KTRA annual total liabilities has changed by -$803.00 K (-24.72%)

What is Kintara Therapeutics quarterly total liabilities?

The current quarterly total liabilities of KTRA is $2.44 M

What is the all time high quarterly total liabilities for Kintara Therapeutics?

Kintara Therapeutics all-time high quarterly total liabilities is $14.23 M

What is Kintara Therapeutics quarterly total liabilities year-on-year change?

Over the past year, KTRA quarterly total liabilities has changed by -$1.06 M (-30.20%)